Reframing drug-related violence in a changing global landscape: Introduction to the special issue [0.03%]
在变幻莫测的全球格局中重新解读毒品相关暴力问题——本期专题导语
Marieke Liem,Kim Moeller,Laura Atuesta
Marieke Liem
Perceived harm reduction impact of a drug checking service in Vienna: A qualitative study among current and prospective service users [0.03%]
维也纳一项药物检查服务的减害影响感知情况：现使用者与潜在使用者中的定性研究
Alexandra Karden,Tobias Fragner,Tiam Ghorab et al.
Alexandra Karden et al.
Background and aims: The evolving landscape of illicit drug markets necessitates effective approaches to harm reduction and addiction prevention for people who use drugs (PWUD). In response, integrated drug checking servi...
Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study [0.03%]
针对有近期注射毒品使用史的监狱服刑人员开展的研究：直接抗病毒疗法治疗丙型肝炎病毒感染后的再感染（SHARP-P研究）
Anna Conway,Jason Grebely,Shane Tillakeratne et al.
Anna Conway et al.
Background: Given sub-optimal harm reduction access, people in prison who inject drugs are at great risk of hepatitis C virus (HCV) infection, including reinfection following successful treatment. In New South Wales, Aust...
Poppers, nitrous, and beyond: Patterns of inhalant use across sexual identity groups in the U.S., 2021-2023 [0.03%]
美国2021-2023年按性取向群体划分的吸入剂使用模式：波普ers、笑气及其他
Megan S Schuler,Michael S Dunbar,Rajeev Ramchand
Megan S Schuler
Purpose: Inhalant use, including "poppers" (e.g., alkyl nitrites), remains disproportionately common among sexual minority adults, yet national data on recent use patterns and behavioral health correlates are limited. ...
Eradication and livelihoods: Household determinants of opium poppy cultivation in Eastern Afghanistan [0.03%]
灭毒与生计：东阿片农户大麻种植的家庭决定因素分析
Ahmad Shah Shinwari,Thomas Herzfeld
Ahmad Shah Shinwari
Background: Despite recent policy interventions and eradication campaigns, opium poppy cultivation remains deeply embedded in the Afghan rural economy, questioning the success of the current anti-drug strategies. The obje...
Nonmedical cannabis legalization and adolescent inpatient cannabis use disorder, 2008-2020: A quasi-experimental analysis [0.03%]
大麻非医疗用途合法化与2008-2020年青少年住院大麻使用障碍：准实验分析
Sunday Azagba,Bijit Roy,Todd Ebling
Sunday Azagba
Background: Evidence on the impact of nonmedical cannabis legalization on adolescent cannabis use disorder (CUD) is inconsistent, with limited data on inpatient encounters. This study assesses whether state nonmedical can...
Impact of health policies on opioid tapering and discontinuation among patients receiving long-term opioid therapy for chronic noncancer pain [0.03%]
卫生政策对慢性非癌痛长期阿片类药物治疗患者的减药和停药的影响
Richard L Morrow,Jane A Buxton,Roy Purssell et al.
Richard L Morrow et al.
Background: Rapid opioid tapering and discontinuation may increase overdose risk, but the influence of opioid-related policies on tapering and discontinuation are unclear. ...
Using drug checking data to model the relationship between the prevalence of fentanyl and xylazine to drug overdose deaths in New York City [0.03%]
利用药物检测数据建立纽约市芬太尼和扎来普隆与药物过量死亡关系的模型
Jeffery Sauer,Yarelix Estrada,Leonardo Dominguez Gomez et al.
Jeffery Sauer et al.
Background: Drug checking is an increasingly common harm reduction service available across the United States. However, evidence of whether drug-checking data is associated with population-level health measures is limited...
The impact of medications for opioid use disorder (MOUD) on retention and recovery capital in recovery housing: An exploratory causal inference analysis [0.03%]
阿片类药物使用障碍(MOUD)治疗对康复住房中患者的留存率和康复资本的影响：一种探索性因果推断分析
Arun Sondhi,David Best,Alessandro Leidi et al.
Arun Sondhi et al.
Background: Medications for Opioid Use Disorder (MOUD), including methadone (MET), sublingual buprenorphine (SL-BPN), extended-release buprenorphine (ER-BPN), and naltrexone (NTX), are increasingly used in recovery housin...
Framing drug policy reform: Third-sector advocacy and the 2024 New South Wales Drug Summit [0.03%]
药物政策改革的框架：第三部门倡导与2024年新南威尔士州药物峰会
Oskar Sachs,Paul Kelaita,Sally Nathan et al.
Oskar Sachs et al.
Background: Drug policy remains a politically and socially contested domain, with third-sector voices often marginalised despite their central role in advocacy and service delivery. The 2024 New South Wales (NSW) Drug Sum...